Biomedical (basic)

Ended Definitive Contract Awarded Last action

Contract number
HHSN266200500042C
Awardee
Awarding agency
Obligated
$17,860,077

Award facts

Contract value 63% obligated
  • $20,860,077.33 Current, with exercised options
  • $28,331,744.33 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Australia

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 8 $48,622
Other Administrative Action 7 · Microbicide design and development teams $0
Funding Only Action 6 · Microbicide DES DEV teams $1,170,357
Funding Only Action 5 $3,088,990
Other Administrative Action 4 $0
Funding Only Action 3 $3,703,439
Other Administrative Action 2 $0
Funding Only Action 1 $6,886,018
Original award $2,962,651

Quick answers

Who was awarded contract HHSN266200500042C?

HHSN266200500042C was awarded to Starpharma PTY LTD by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 28, 2005.

How much is contract HHSN266200500042C worth?

The government has obligated $17,860,077 on HHSN266200500042C. Its current value, with exercised options, is $20,860,077. Its potential value, with all options, is $28,331,744.

Was contract HHSN266200500042C competed?

The extent of competition for HHSN266200500042C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login